SENESCO TECHNOLOGIES INC
10KSB, EX-27, 2000-09-28
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SENESCO TECHNOLOGIES INC, 10KSB, EX-10.15, 2000-09-28
Next: DOBSON COMMUNICATIONS CORP, 3, 2000-09-28



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL  INFORMATION EXTRACTED FROM THE AUDITED
CONSOLIDATED  FINANICAL  STATEMENTS  AT JUNE 30,  2000 AND FOR THE TWELVE  MONTH
PERIOD  ENDED JUNE 30, 2000 WHICH ARE INCLUDED IN THE  REGISTRANT'S  FORM 10-KSB
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK>                         0001035354
<NAME>                        Senesco Technologies, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. Dollars

<S>                             <C>
<PERIOD-TYPE>                   Year
<FISCAL-YEAR-END>                              JUN-30-2000
<PERIOD-START>                                 JUL-01-1999
<PERIOD-END>                                   JUN-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         1,555,749
<SECURITIES>                                   0
<RECEIVABLES>                                  0
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               1,564,972
<PP&E>                                         89,209
<DEPRECIATION>                                 18,596
<TOTAL-ASSETS>                                 1,743,862
<CURRENT-LIABILITIES>                          225,304
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       78,726
<OTHER-SE>                                     1,439,832
<TOTAL-LIABILITY-AND-EQUITY>                   1,518,558
<SALES>                                        0
<TOTAL-REVENUES>                               0
<CGS>                                          0
<TOTAL-COSTS>                                  2,444,869
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             47
<INCOME-PRETAX>                                (2,444,916)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (2,444,916)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (2,444,916)
<EPS-BASIC>                                    (.39)
<EPS-DILUTED>                                  (.39)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission